Home R&D Page 10

R&D

The gene editing revolution

Raw materials. Risk assessment for excipients

SOCRATES: Ticagrelor flops in stroke prevention study

Mymetics Announces Successful Preclinical Results With Malaria Transmission-Blocking Vaccine Candidate

First oral treatment for Fabry disease recommended for approval in the...

Space and Technology. Drug development at the International Space Station

Empagliflozin: new results showing the reduction of cardiovascular events

ODYSSEY: a study to assess the potenital cardiovascular benefit of alirocumab

Conditional approval for blinatumomab to treat B-precursor ALL

Mepolizumab in the treatment of asthma

1...91011...17Page 10 of 17
© © 2025 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151